bendroflumethiazide has been researched along with Hypertrophy, Left Ventricular in 4 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Despite regression of left ventricular hypertrophy, there was no associated improvement in diastolic function." | 2.79 | Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy. ( Baksi, AJ; Barron, AJ; Fitzgerald, D; Hughes, AD; Jabbour, RJ; Mayet, J; O'Brien, E; Poulter, N; Sever, P; Sharp, A; Stanton, A; Surendran, P; Thom, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barron, AJ | 1 |
| Hughes, AD | 1 |
| Sharp, A | 1 |
| Baksi, AJ | 1 |
| Surendran, P | 1 |
| Jabbour, RJ | 1 |
| Stanton, A | 1 |
| Poulter, N | 1 |
| Fitzgerald, D | 1 |
| Sever, P | 1 |
| O'Brien, E | 1 |
| Thom, S | 1 |
| Mayet, J | 2 |
| Ripley, DP | 1 |
| Negrou, K | 1 |
| Oliver, JJ | 1 |
| Worthy, G | 1 |
| Struthers, AD | 1 |
| Plein, S | 1 |
| Greenwood, JP | 1 |
| Ariff, B | 1 |
| Wasan, B | 1 |
| Chapman, N | 1 |
| Shahi, M | 1 |
| Poulter, NR | 1 |
| Sever, PS | 1 |
| Foale, RA | 1 |
| Thom, SA | 1 |
| Spencer, CG | 1 |
| Gurney, D | 1 |
| Blann, AD | 1 |
| Beevers, DG | 1 |
| Lip, GY | 1 |
3 trials available for bendroflumethiazide and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Drug Therapy, Combi | 2014 |
Aortic remodelling following the treatment and regression of hypertensive left ventricular hypertrophy: a cardiovascular magnetic resonance study.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Aorta, Th | 2015 |
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Cro | 2002 |
1 other study available for bendroflumethiazide and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy.
Topics: Adult; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Cardiac Output; Echocardiograph | 2000 |